Keyphrases
Atrial Fibrillation
100%
Ablation
95%
Atrial Fibrillation Recurrence
67%
Nationwide Registry
57%
Denmark
57%
Hypertrophic Cardiomyopathy
54%
Nationwide Register Study
54%
Recurrence Rate
41%
Temporal Trends
30%
Pharmacotherapy
30%
Comorbidity
30%
Retrospective Cohort Study
27%
Body Mass Index
27%
Long-run Risk
27%
Patient Insights
27%
High Age
27%
Catheter Ablation
27%
Registry-based
27%
Supraventricular Tachycardia
27%
Rate Limiting
27%
Cryoablation
27%
Atrial Fibrillation Ablation
21%
Hazard Ratio
21%
Ectopic Atrial Tachycardia
16%
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
16%
Confidence Interval
14%
Heart Failure
13%
Antiarrhythmic Drugs
10%
Early Ablation
10%
Accessory Pathway
10%
Nationwide Registers
9%
AIMS™
9%
Oral Anticoagulants
8%
Persistent Atrial Fibrillation
7%
Morbid Obesity
7%
Normal Weight
7%
Overweight Patient
7%
Cardioversion
7%
Hospitalization
6%
Beta-blockers
6%
Ischemic Stroke
6%
Number of Patients
6%
Diagnosis-to-ablation Time
6%
Outpatient Follow-up
6%
Patient Characteristics
6%
Cumulative Incidence
5%
Ischemic Heart Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
54%
Comorbidity
29%
Antiarrhythmic Agent
29%
Recurrent Disease
27%
Hypertrophic Cardiomyopathy
27%
Cohort Study
27%
Pharmacotherapy
27%
Supraventricular Tachycardia
27%
Atrioventricular Nodal Reentry Tachycardia
22%
Ectopic Atrial Tachycardia
22%
Obesity
11%
Beta Adrenergic Receptor Blocking Agent
9%
Anticoagulant Agent
7%
Recurrence Risk
6%
Medicine and Dentistry
Atrial Fibrillation
57%
Hypertrophic Cardiomyopathy
54%
Apoplexy
30%
Retrospective Cohort Study
27%
Recurrence Risk
27%
Catheter Ablation
27%
Hazard Ratio
10%
Antithrombotic
7%
Recurrent Disease
7%
Heart Failure
6%
Outpatient
6%
Prevalence
6%
Patient Characteristics
6%
